Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|August 6, 2020
The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial CancerOliviero Marinelli, Maria Beatrice Morelli, Daniela Annibali, et al.Frontiers in Oncology|November 16, 2020
Biological Function of PD-L2 and Correlation With Overall Survival in Type II Endometrial CancerOliviero Marinelli, Daniela Annibali, Maria Beatrice Morelli, et al.Reproductive Sciences (Thousand Oaks, Calif.)|February 15, 2018
Acute Drug Effects on the Human Placental Tissue: The Development of a Placental Murine Xenograft ModelMagali Verheecke, Els Hermans, Sandra Tuyaerts, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocolsMelissa Dullaers, Karine Breckpot, Sonja Van Meirvenne, et al.Journal for Immunotherapy of Cancer|January 11, 2024
Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanomaJens Tijtgat, Xenia Geeraerts, Anais Boisson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 18, 2011
Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanomaSofie Wilgenhof, An M T Van Nuffel, Jurgen Corthals, et al.Journal for Immunotherapy of Cancer|November 19, 2024
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicityFien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, et al.BMC Cancer|May 30, 2019
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancerSandra Tuyaerts, An M T Van Nuffel, Eline Naert, et al.Cancer Immunology, Immunotherapy : CII|July 2, 2024
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumorsManon Vounckx, Jens Tijtgat, Latoya Stevens, et al.Neuro-Oncology|October 15, 2024
Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade gliomaJohnny Duerinck, Louise Lescrauwaet, Iris Dirven, et al.Pageof 6